Algeria vs Bosnia and Herzegovina: Statin use vs. average non-HDL cholesterol levels
Algeria
3.3
in 2018
Bosnia and Herzegovina
3.3
in 2018
Algeria rank
95th
Bosnia and Herzegovina rank
95th
Statin use vs. average non-HDL cholesterol levels over time
- Algeria
- Bosnia and Herzegovina
How they compare
Algeria currently reports 3.3 against 3.3 in Bosnia and Herzegovina, a difference of 0.
The two have swapped places 8 times across 39 shared years of data; in 1980 it was Bosnia and Herzegovina ahead.
Algeria ranks 95th and Bosnia and Herzegovina ranks 95th of 191 countries.
Across the 4 decades both report, Algeria averaged higher in 2 and Bosnia and Herzegovina in 2.
Head to head by decade
| Decade | Algeria | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.42 | 3.68 | 0.26 | Bosnia and Herzegovina |
| 1990s | 3.63 | 3.7 | 0.07 | Bosnia and Herzegovina |
| 2000s | 3.59 | 3.55 | 0.04 | Algeria |
| 2010s | 3.41 | 3.36 | 0.0556 | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Algeria or Bosnia and Herzegovina?
- Algeria, at 3.3 against 3.3 in Bosnia and Herzegovina as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Algeria and Bosnia and Herzegovina?
- 0, with Algeria ahead.
- How many years of comparable data are there for Algeria and Bosnia and Herzegovina?
- 39 years are reported by both, from 1980 to 2018.
- How do Algeria and Bosnia and Herzegovina rank globally for statin use vs. average non-hdl cholesterol levels?
- Algeria ranks 95th and Bosnia and Herzegovina ranks 95th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.